Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2015, Article ID 610281, 8 pages
http://dx.doi.org/10.1155/2015/610281
Research Article

Screening and Identification of ssDNA Aptamer for Human GP73

1Kingmed College of Laboratory Medicine, Guangzhou Medical University, Guangzhou 510182, China
2Department of Laboratory Medicine, The First Affiliated Hospital, Guangzhou Medical University, Guangzhou 510120, China

Received 29 June 2015; Accepted 8 September 2015

Academic Editor: William Z. Suo

Copyright © 2015 Jingchun Du et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Jemal, F. Bray, M. M. Center, J. Ferlay, E. Ward, and D. Forman, “Global cancer statistics,” CA Cancer Journal for Clinicians, vol. 61, no. 2, pp. 69–90, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. H. B. El-Serag, A. C. Mason, and C. Key, “Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States,” Hepatology, vol. 33, no. 1, pp. 62–65, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. J. Bruix and M. Sherman, “Management of hepatocellular carcinoma: an update,” Hepatology, vol. 53, no. 3, pp. 1020–1022, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. M. Schwartz, S. Roayaie, and M. Konstadoulakis, “Strategies for the management of hepatocellular carcinoma,” Nature Clinical Practice Oncology, vol. 4, no. 7, pp. 424–432, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Zhou, L. Li, L. Hu, and T. Peng, “Golgi phosphoprotein 2 (GOLPH2/GP73/GOLM1) interacts with secretory clusterin,” Molecular Biology Reports, vol. 38, no. 3, pp. 1457–1462, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. R. Masuzaki, S. J. Karp, and M. Omata, “New serum markers of hepatocellular carcinoma,” Seminars in Oncology, vol. 39, no. 4, pp. 434–439, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M.-C. Ba, H. Long, Y.-Q. Tang, and S.-Z. Cui, “GP73 expression and its significance in the diagnosis of hepatocellular carcinoma: a review,” International Journal of Clinical and Experimental Pathology, vol. 5, no. 9, pp. 874–881, 2012. View at Google Scholar · View at Scopus
  8. B. Hu, X. H. Tian, J. Sun, and X. J. Meng, “Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis,” International Journal of Molecular Sciences, vol. 14, no. 12, pp. 23559–23580, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. Y. Mao, H. Yang, H. Xu et al., “Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma,” Gut, vol. 59, no. 12, pp. 1687–1693, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. X. Bao, Q. Cao, Y. Yang et al., “Expression and prognostic significance of Golgiglycoprotein73 (GP73) with Epithelial-Mesenchymal Transition (EMT) related molecules in Hepatocellular Carcinoma (HCC),” Diagnostic Pathology, vol. 8, article 197, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Tuerk and L. Gold, “Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase,” Science, vol. 249, no. 4968, pp. 505–510, 1990. View at Publisher · View at Google Scholar · View at Scopus
  12. A. D. Ellington and J. W. Szostak, “Selection in vitro of single-stranded DNA molecules that fold into specific ligand-binding structures,” Nature, vol. 355, no. 6363, pp. 850–852, 1992. View at Publisher · View at Google Scholar · View at Scopus
  13. P. R. Bouchard, R. M. Hutabarat, and K. M. Thompson, “Discovery and development of therapeutic aptamers,” Annual Review of Pharmacology and Toxicology, vol. 50, pp. 237–257, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Nutiu and Y. Li, “Aptamers with fluorescence-signaling properties,” Methods, vol. 37, no. 1, pp. 16–25, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Zuker, “Mfold web server for nucleic acid folding and hybridization prediction,” Nucleic Acids Research, vol. 31, no. 13, pp. 3406–3415, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. A. S. Lok, R. K. Sterling, J. E. Everhart et al., “Des-γ-carboxy prothrombin and α-fetoprotein as biomarkers for the early detection of hepatocellular carcinoma,” Gastroenterology, vol. 138, no. 2, pp. 493–502, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. C. M. Sturgeon, M. J. Duffy, B. R. Hofmann et al., “National academy of clinical biochemistry laboratory medicine practice guidelines for use of tumor markers in liver, bladder, cervical, and gastric cancers,” Clinical Chemistry, vol. 56, no. 6, pp. e1–e48, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. J. A. Marrero, P. R. Romano, O. Nikolaeva et al., “GP73, a resident Golgi glycoprotein, is a novel serum marker for hepatocellular carcinoma,” Journal of Hepatology, vol. 43, no. 6, pp. 1007–1012, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. C. D. M. Witjes, S. M. van Aalten, E. W. Steyerberg et al., “Recently introduced biomarkers for screening of hepatocellular carcinoma: a systematic review and meta-analysis,” Hepatology International, vol. 7, no. 1, pp. 59–64, 2013. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Zhou, M. R. Battig, and Y. Wang, “Aptamer-based molecular recognition for biosensor development,” Analytical and Bioanalytical Chemistry, vol. 398, no. 6, pp. 2471–2480, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Soontornworajit and Y. Wang, “Nucleic acid aptamers for clinical diagnosis: cell detection and molecular imaging,” Analytical and Bioanalytical Chemistry, vol. 399, no. 4, pp. 1591–1599, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. B. I. Escudero-Abarca, S. H. Suh, M. D. Moore, H. P. Dwivedi, and L.-A. Jaykus, “Selection, characterization and application of nucleic acid aptamers for the capture and detection of human norovirus strains,” PLoS ONE, vol. 9, no. 9, Article ID e106805, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. F.-B. Wang, Y. Rong, M. Fang et al., “Recognition and capture of metastatic hepatocellular carcinoma cells using aptamer-conjugated quantum dots and magnetic particles,” Biomaterials, vol. 34, no. 15, pp. 3816–3827, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. R. D. Kladney, G. A. Bulla, L. Guo et al., “GP73, a novel Golgi-localized protein upregulated by viral infection,” Gene, vol. 249, no. 1-2, pp. 53–65, 2000. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Zhang and B. Cao, “Generation and characterization of an anti-GP73 monoclonal antibody for immunoblotting and sandwich ELISA,” The Journal of Biomedical Research, vol. 26, no. 6, pp. 467–473, 2012. View at Publisher · View at Google Scholar · View at Scopus